News and Announcements

AstraZeneca breast cancer drug receives EU approval

By Abigail Townsend

Date: Thursday 23 Jul 2026

(Sharecast News) - A breast cancer drug developed by AstraZeneca has been approved in the European Union for the treatment of certain types of the disease, the pharmaceutical giant announced on Thursday.
Used in combination with a CDK4/6 inhibitor, Etcamah has been approved by Brussels for the treatment of adults with...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page